Genetic and pharmacologic hydrogen sulfide therapy attenuates ischemia-induced heart failure in mice.
about
Emergence of hydrogen sulfide as an endogenous gaseous signaling molecule in cardiovascular diseaseHydrogen sulfide chemical biology: pathophysiological roles and detectionRole of cystathionine γ-lyase/hydrogen sulfide pathway in cardiovascular disease: a novel therapeutic strategy?The methionine sulfoxide reduction system: selenium utilization and methionine sulfoxide reductase enzymes and their functionsMitochondrial biogenesis: regulation by endogenous gases during inflammation and organ stressThe Cardioprotective Effects of Hydrogen Sulfide in Heart Diseases: From Molecular Mechanisms to Therapeutic PotentialCardioprotective effects of a novel hydrogen sulfide agent-controlled release formulation of S-propargyl-cysteine on heart failure rats and molecular mechanismsCysteine dioxygenase 1 is a tumor suppressor gene silenced by promoter methylation in multiple human cancers.Protective effect of hydrogen sulphide against myocardial hypertrophy in miceNrf2 deficiency exaggerates doxorubicin-induced cardiotoxicity and cardiac dysfunction.Induction of microRNA-21 with exogenous hydrogen sulfide attenuates myocardial ischemic and inflammatory injury in miceThe cardioprotective actions of hydrogen sulfide in acute myocardial infarction and heart failureSolubility and permeation of hydrogen sulfide in lipid membranes.Chemoselective reduction-based fluorescence probe for detection of hydrogen sulfide in living cells.Hydrogen sulfide cytoprotective signaling is endothelial nitric oxide synthase-nitric oxide dependent.Triterpenoid dihydro-CDDO-trifluoroethyl amide protects against maladaptive cardiac remodeling and dysfunction in mice: a critical role of Nrf2.Gaseous hydrogen sulfide protects against myocardial ischemia-reperfusion injury in mice partially independent from hypometabolismHydrogen sulfide provides cardioprotection against myocardial/ischemia reperfusion injury in the diabetic state through the activation of the RISK pathwaymiRNA-30 family inhibition protects against cardiac ischemic injury by regulating cystathionine-γ-lyase expression.Cardioprotective effects of hydrogen sulfideHydrogen sulfide improves cardiomyocytes electrical remodeling post ischemia/reperfusion injury in ratsHydrogen sulfide attenuates high fat diet-induced cardiac dysfunction via the suppression of endoplasmic reticulum stress.Ginkgolide B increases hydrogen sulfide and protects against endothelial dysfunction in diabetic rats.Knockout of the murine cysteine dioxygenase gene results in severe impairment in ability to synthesize taurine and an increased catabolism of cysteine to hydrogen sulfide.Hydrogen sulfide mitigates homocysteine-mediated pathological remodeling by inducing miR-133a in cardiomyocytesNrf2 enhances myocardial clearance of toxic ubiquitinated proteinsMitochondrial dysfunction and biogenesis: do ICU patients die from mitochondrial failure?Defining the minimally effective dose and schedule for parenteral hydrogen sulfide: long-term benefits in a rat model of hindlimb ischemia.Role of Hydrogen Sulfide in Ischemia-Reperfusion Injury.Hydrogen sulfide in biochemistry and medicine.Hydrogen sulfide preconditioning protects against myocardial ischemia/reperfusion injury in rats through inhibition of endo/sarcoplasmic reticulum stressThe polysulfide diallyl trisulfide protects the ischemic myocardium by preservation of endogenous hydrogen sulfide and increasing nitric oxide bioavailability.Biological thiols-triggered hydrogen sulfide releasing microfibers for tissue engineering applications.Hydrogen sulfide and PKG in ischemia-reperfusion injury: sources, signaling, accelerators and brakes.Interactions between oxygen homeostasis, food availability, and hydrogen sulfide signaling.Redox signaling pathways involved in neuronal ischemic preconditioningThiol reactive probes and chemosensors.Garlic-Derived Organic Polysulfides and Myocardial ProtectionDesign, Synthesis, and Cardioprotective Effects of N-Mercapto-Based Hydrogen Sulfide Donors.Sodium Sulfide Attenuates Ischemic-Induced Heart Failure by Enhancing Proteasomal Function in an Nrf2-Dependent Manner.
P2860
Q26823796-D532A7E8-49B5-42F8-8EBD-E7713461C899Q26824672-E77D8466-C249-44C7-B0E3-6C90DEE381F0Q26827551-91892ED6-7626-4F89-8C52-7DFF7F259E90Q26864476-A9406994-0FC4-414B-B5CD-01A0704A3610Q27025057-DB511576-040D-4114-9069-395AD70EE89BQ28083965-C1EBC123-A2E0-458E-B3DC-9FFD44612E82Q28534567-C21FA2BB-7694-40A2-B404-D1AE66D731E1Q31101539-253BBDD2-E24C-4B28-BFB1-AB183CAA3A7CQ33618317-A28951A9-1131-4931-8CF6-DD83864A1E4BQ33660939-ADA19F94-6ACE-4C17-AE21-17120CA797DAQ33874591-726334F7-CA28-41D1-9F4B-CB26AF5C9BA5Q33876378-0C84D391-CC20-47AB-B7E7-8194C9151FF5Q34235296-8960AFB1-6B8F-4C08-B854-9D9B25C76FE8Q34368023-F58ADB72-C6FD-4571-A914-2AA177166DFAQ34403540-E804C10E-48B3-4483-9789-C88812F38FC6Q34427625-F825E53F-9835-45D9-8504-FBEDE7424381Q34722817-F1F1EF8A-5E68-402D-85BE-0099BE7C4C5CQ34728629-9C541F7F-0512-4E7E-AAC9-FD549727C025Q34811514-A1E4EDCB-F7BF-463C-B4F8-0F7CE770CB8DQ35115617-42CD5282-ACDF-48F1-9F2F-8174FA0F3818Q35144947-9EF54523-0E21-4063-9FD0-367D1BB90759Q35181153-6717022C-0BF2-48BB-B76F-749CF3EB4A00Q35190374-E98778ED-02A6-4F59-8514-AF77DD3F70EDQ35321771-93E3F024-B683-4006-8EB3-DD7C16440DF3Q35561647-7ECE8E60-D5EB-4E65-AFC3-5669210B9AA7Q35565746-683B15E8-3F65-4322-A1B5-B106D526DAF0Q35574085-3D1A280D-8282-4BB9-84A5-2AE6FACC27D2Q35616326-02984639-EF7B-4330-AF19-A8C371964E99Q35647095-B351128D-280E-4C0D-A2E2-9E67F470BF94Q35929408-66FC0DC2-489F-4FE4-8D8C-D820052BD455Q36014153-57174DFD-F379-42BD-BEC1-330F0FE880AAQ36042694-710DB54C-B3EC-4CC1-A014-4CBB36D53C0FQ36173769-CB4A4274-E7AE-4B2E-B01B-D3B596D40F15Q36341617-19B2722F-85E9-4B89-95A3-C93371F700A9Q36450391-3FCD5856-1EA9-4453-B3B0-01153802868CQ36460627-61E9AB30-9916-4C50-B645-262FE4A1EE9EQ36468604-47FFDB10-DCE3-486D-837A-EA33B8A1EE49Q36498005-AB549722-602B-43DD-86F8-1B302AC519EBQ36617377-C608A79E-37A6-415A-AD0F-484F30FC2C42Q36784081-64424BCC-C1FF-4A34-A0CB-DA0506A11730
P2860
Genetic and pharmacologic hydrogen sulfide therapy attenuates ischemia-induced heart failure in mice.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Genetic and pharmacologic hydr ...... induced heart failure in mice.
@ast
Genetic and pharmacologic hydr ...... induced heart failure in mice.
@en
type
label
Genetic and pharmacologic hydr ...... induced heart failure in mice.
@ast
Genetic and pharmacologic hydr ...... induced heart failure in mice.
@en
prefLabel
Genetic and pharmacologic hydr ...... induced heart failure in mice.
@ast
Genetic and pharmacologic hydr ...... induced heart failure in mice.
@en
P2093
P2860
P1433
P1476
Genetic and pharmacologic hydr ...... induced heart failure in mice.
@en
P2093
Arun Ramachandran
Chad K Nicholson
David J Lefer
John W Calvert
John W Elrod
Marah Elston
Saurabh Jha
Susheel Gundewar
P2860
P356
10.1161/CIRCULATIONAHA.109.920991
P407
P577
2010-06-21T00:00:00Z